Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...

Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB February 26, 2026 1:00 PM ...

While Gov. Ned Lamont is calling for the overall state budget to increase by $1.2 billion from the current year, legislators and advocacy groups are concerned about cuts and changes to various ...

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...

The struggle for geopolitical supremacy is rapidly becoming a struggle over one critical resource - rare earth magnets. They will determine whether the United States can build military equipment at ...

The National Nuclear Security Administration’s deputy administrator for defense programs argued in a memo last month that Los Alamos National Laboratory should increase its annual production of ...

Engineers at Washington University in St. Louis have developed a new class of protein-based fibers modeled on the aligned ...

Incyte (Nasdaq:INCY) today announced financial results for the fourth quarter and full year ended December 31, 2025 and provided full year 2026 financial guidance.

North East school has partnered with solar and space physics experts from Northumbria University for a project supported by a Royal Society Partnership Grant which aims to bring academic research and ...

A few thoughts about a battle between teams with a combined 20 state championships and winning streaks that both set state records. Alton Marquette (18-11) advanced to face Gillespie (17-12) for the ...